Published in Biotech Business Week, January 1st, 2007
The acquisition of CellMed was announced on 4 March 2005 and the press release is available on the Biocompatibles website.
The transaction involved initial equity and cash consideration paid in installments (the Initial Consideration), plus additional potential performance payments based on CellMed's cash generation from specified programs. The final installment of the Initial Consideration of approximately 1.1 million shares will be issued by December 31, 2006 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.